)
)
Glaukos Investor Relations Material
Latest events
Q3 2024
Glaukos
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Glaukos Corporation
Access all reports
Glaukos Corporation is a clinical-stage medical device company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment and management of glaucoma, corneal disorders and retinal diseases.
Key slides for Glaukos Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Glaukos Corporation
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
GKOS
Country
🇺🇸 United States